Bonding, Ion Mobility, and Rate-Limiting Steps in Deintercalation Reactions with ThCr₂Si₂-type KNi₂Se₂ by James R. Neilson (1896145)

“…Furthermore, the fully oxidized compounds, K_0.25Ni_1.5Se₂, spontaneously convert from the tetrahedral [NiSe₄]-containing ThCr₂Si₂ structure to a vacancy-ordered NiAs structure with [NiSe₆] octahedra. …”

Bonding, Ion Mobility, and Rate-Limiting Steps in Deintercalation Reactions with ThCr₂Si₂-type KNi₂Se₂ by James R. Neilson (1896145)

“…Furthermore, the fully oxidized compounds, K_0.25Ni_1.5Se₂, spontaneously convert from the tetrahedral [NiSe₄]-containing ThCr₂Si₂ structure to a vacancy-ordered NiAs structure with [NiSe₆] octahedra. …”

Bonding, Ion Mobility, and Rate-Limiting Steps in Deintercalation Reactions with ThCr₂Si₂-type KNi₂Se₂ by James R. Neilson (1896145)

“…Furthermore, the fully oxidized compounds, K_0.25Ni_1.5Se₂, spontaneously convert from the tetrahedral [NiSe₄]-containing ThCr₂Si₂ structure to a vacancy-ordered NiAs structure with [NiSe₆] octahedra. …”

Changes in the normalized volume <i>v</i> = V/V₀ of HEK293 cells in response to sequential application of sucrose and <i>myo</i>-inositol solutions of the same osmolalit... by Joseph Andronic (700242)

“…<p>The cells were bathed initially (<i>time</i> < ∼30 s) in isotonic growth medium (300 mOsm) and then exposed to a 100-mOsm sucrose solution. The strongly hypotonic sucrose solution (<i>filled symbols</i>) caused fast cell swelling to a transient maximum volume <i>v</i>_max of ∼1.6 within the first 2–3 min. …”

The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 6 by Jin Zhou (90734)

“…<p>The effects of GSK360A on <b>(A)</b> mNSS, <b>(B)</b> beam balance, <b>(C)</b> foot fault and <b>(D)</b> hind limb performance at 5 hours, 1 day, 1 week and 3 weeks after stroke. …”

DPI, NAC and resveratrol decrease lipolysis. by Sarah A. Krawczyk (172699)

The novel <i>carboxylesterase 1</i> variant c.662A>G may decrease the bioactivation of oseltamivir in humans by Jaeseong Oh (3947381)

“…A novel <i>CES1</i> c.662A>G single nucleotide polymorphism (SNP) was predicted to decrease CES1 enzymatic activity in an <i>in silico</i> analysis. …”

This is the raw data of Western blot in Met-5A cell. by Yangyang Yin (14323701)

Subjects:

JARID1B downregulation results in the decrease of cell invasion capability. by Yung-Ting Kuo (736349)

Postnatal CDPPB treatment decreased [¹¹C]PBR accumulation in saline-exposed offspring, but not in offspring prenatally exposed to LPS. by Dany Arsenault (229311)

“…<p>Postnatal CDPPB treatment decreased the accumulation of [¹¹C]PBR in the olfactory bulb, cerebellum, hippocampus, striatum, hypothalamus and the whole brain of the offspring prenatally exposed to saline solution (A). …”

Intracellular ROS decrease mediated by TAT-fused protein delivery. by Cecilia L. Balaban (4424212)

Inhibition of F/P tyrosine kinase by imatinib in CEL patients decreased phosphorylation of JAK2, Stat3 and Stat5 in a time-dependent manner. by Bin Li (39349)

The ATR IR signal decreases with decreasing dilutions of cells. by Allison L. Stelling (392086)

“…<p>Shown is a box plot for serial dilutions of a glioblastoma cell suspension. …”

BSO treatment decreases E2F target gene expression. by Hannes M. Findeisen (353287)

Learning curve of STEP as performed by the early career surgeon. by Yoshiro Imai (11492315)

PA sGCβ expression is persistently decreased after neonatal hyperoxia exposure. by Marta Perez (526067)

Sildenafil treatment during recovery does not affect hyperoxia-induced decreases in alveolar counts. by Marta Perez (526067)

(Genetrank) saturation plots (Def. 5) for <i>τ</i> = 20. by Augusto Sales de Queiroz (14070458)

Twenty-four hour monitoring revealed increased interaction and decreased activity during daytime in <i>Cdkl5</i> -/Y mice. by Kosuke Okuda (5150393)

“…The genotype difference during the whole period was significant (p = 0.0012). (ii) Activity level (A.U.). The activity level of <i>Cdkl5</i> -/Y mice is significantly decreased compared to <i>Cdkl5</i> +/Y mice during daytime (p = 0.0004), but not in the nighttime (p = 0.1535). …”

Increased AQP2 expression by a vasopressin analogue is decreased by diphenyleneiodonium. by Eric Féraille (513934)